Animal models of muscular dystrophy

R Ng, GB Banks, JK Hall, LA Muir, JN Ramos… - Progress in molecular …, 2012 - Elsevier
The muscular dystrophies (MDs) represent a diverse collection of inherited human
disorders, which affect to varying degrees skeletal, cardiac, and sometimes smooth muscle …

Fukutin-related protein: from pathology to treatments

C Ortiz-Cordero, K Azzag, RCR Perlingeiro - Trends in cell biology, 2021 - cell.com
Fukutin-related protein (FKRP) is a glycosyltransferase involved in the functional
glycosylation of α-dystroglycan (DG), a key component in the link between the cytoskeleton …

Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery

C Qiao, CH Wang, C Zhao, P Lu, H Awano, B Xiao… - Molecular Therapy, 2014 - cell.com
Mutations in fukutin-related protein (FKRP) gene cause a wide spectrum of disease
phenotypes including the mild limb-girdle muscular dystrophy 2I (LGMD2I), the severe …

Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle

EP Rader, R Turk, T Willer, D Beltrán… - Proceedings of the …, 2016 - National Acad Sciences
Dystroglycan (DG) is a highly expressed extracellular matrix receptor that is linked to the
cytoskeleton in skeletal muscle. DG is critical for the function of skeletal muscle, and muscle …

[HTML][HTML] Glucocorticoid steroid and alendronate treatment alleviates dystrophic phenotype with enhanced functional glycosylation of α-dystroglycan in mouse model of …

B Wu, SN Shah, P Lu, SM Richardson… - The American journal of …, 2016 - Elsevier
Fukutin-related protein-muscular dystrophy is characterized by defects in glycosylation of α-
dystroglycan with variable clinical phenotypes, most commonly as limb-girdle muscular …

A new mouse model of limb-girdle muscular dystrophy type 2I homozygous for the common L276I mutation mimicking the mild phenotype in humans

TO Krag, J Vissing - Journal of neuropathology and …, 2015 - academic.oup.com
Limb-girdle muscular dystrophy type 2I (LGMD2I) is caused by mutations in the Fukutin-
related protein (FKRP) gene, leading to inadequate glycosylation of α-dystroglycan, an …

Skeletal muscle contractile properties in a novel murine model for limb girdle muscular dystrophy 2i

JD Rehwaldt, BD Rodgers… - Journal of Applied …, 2017 - journals.physiology.org
Limb-girdle muscular dystrophy (LGMD) 2i results from mutations in fukutin-related protein
and aberrant α-dystroglycan glycosylation. Although this significantly compromises muscle …

Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i

JW Maricelli, DR Kagel, YM Bishaw… - Journal of Applied …, 2017 - journals.physiology.org
The fukutin-related protein P448L mutant mouse replicates many pathologies common to
limb girdle muscular dystrophy 2i (LGMD2i) and is a potentially strong candidate for relevant …

Animal models for muscle disease and muscle gene therapy

SM Shrader, R Wrighten, BF Smith - Muscle gene therapy, 2019 - Springer
It is currently estimated that roughly 50,000 Americans are affected by some form of
muscular dystrophy and many others by the various forms of myopathies. Animal models are …

Contribution of dysferlin deficiency to skeletal muscle pathology in asymptomatic and severe dystroglycanopathy models: generation of a new model for Fukuyama …

M Kanagawa, Z Lu, C Ito, C Matsuda, K Miyake, T Toda - Plos one, 2014 - journals.plos.org
Defects in dystroglycan glycosylation are associated with a group of muscular dystrophies,
termed dystroglycanopathies, that include Fukuyama congenital muscular dystrophy …